Testing a virtual reality game for attention in neurodivergent children
Tests a virtual reality game in children aged 9 to 18 with autism or ADHD.
Plain-language title generated from the registry record
Registry title: How Virtual Reality Can Help Neurodivergent Children Improve Their Attention
Key facts
- Where
- Old Westbury, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 9 and 18 years old?
Source: NCT07341204, who can take part
Where in United States
- Inclusive Sports and Fitness, Inc.Old Westbury, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- New York Institute of Technology
- Trial code
- NCT07341204
- Record updated
- 14 January 2026
- Original description
The goal of this study is to determine whether playing a virtual reality (VR) game can help neurodivergent children pay attention for extended periods. The study includes children ages 9 to 18 who have autism, ADHD, learning differences, or movement coordination challenges. The program lasts for 6 weeks. During this period, children will play a VR game twice per week, with each session lasting 25 minutes.Read full original descriptionShow less
Improvement of Sustained Attention Through Immersive Virtual Reality in Neurodivergent Children
The goal of this study is to determine whether playing a virtual reality (VR) game can help neurodivergent children pay attention for extended periods. The study includes children ages 9 to 18 who have autism, ADHD, learning differences, or movement coordination challenges. The program lasts for 6 weeks. During this period, children will play a VR game twice per week, with each session lasting 25 minutes.
Inclusion: Clinical diagnosis of ASD, ADHD, SLD, or DCD confirmed by a licensed clinician or documented in medical/educational records (DSM-5 or equivalent); Parent/guardian consent and participant assent (age-appropriate); Ability to follow simple verbal instructions and to participate in 25-minute VR sessions twice weekly for 6 weeks; Stable medication regimen for attention- or behavior-related medications for ≥4 weeks prior to baseline (or not taking such medications); Visual and auditory ability adequate for VR tasks (with or without usual corrective lenses/hearing aids); Availability to attend all scheduled sessions at the clinical site across the 6-week period.
Exclusion: Recent (within 6 months) significant brain injury or neurosurgery. Significant history of motion sickness, severe vestibular disorder, or prior intolerance to immersive VR; History of photosensitive epilepsy or any uncontrolled seizure disorder; Severe intellectual disability or severe communication impairment that prevents understanding/participation (e.g., non-responsive to simple commands required by the VR tasks); Severe visual, auditory, or motor impairment that prevents safe or functional use of the VR system (e.g., inability to hold controllers or view the headset even with correction); Any medical or implanted device contraindicated for VR/headset use (if applicable).